Site-Wide License

Showing 229–240 of 279 results

  • Liver Cancer: Disease and Pipeline Analysis

    $2,960.00$5,920.00
  • EDC and ePRO Market Trends and Service Provider Performance

    $4,900.00$9,800.00
  • Phase I Study Trends and Market Outlook (2013)

    $4,900.00$9,800.00
  • Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing

    $3,260.00$6,520.00
  • CRO Quality Benchmarking – Phase II/III Service Providers (5th edition)

    $6,800.00$13,600.00
  • Medical Device: Clinical Development Market Assessment

    $3,960.00$7,920.00
  • Pancreatic Cancer: Disease and Pipeline Analysis

    $2,960.00$5,920.00
  • Sunshine Act: Pharma Impact – Changes in US Physician Behavior

    $4,900.00$9,800.00
  • Late Phase Market Overview and Outlook (2013)

    $4,900.00$9,800.00
  • Biosimilar Primer: US Primary Care Physicians’ Attitudes, Beliefs, and Intentions

    $750.00$1,500.00
  • Social Media: Best Practices and Strategic Use in Patient Recruitment

    $4,900.00$9,800.00
  • Adoption and Use of eDetailing vs. In-person Detailing in Europe

    $4,900.00$9,800.00